Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Dec 2, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-12-01$49.93/sh−2,500$124,825→ 97,384 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2022.